Amedeo's Top 20

Amedeo Smart

Independent Medical Education


21 March 2022

Multidisciplinary Journal Club

  1. Leboulleux S, Bournaud C, Chougnet CN, Zerdoud S, et al.
    Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.
    N Engl J Med 2022;386:923-932.

  1. Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, et al.
    Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.
    N Engl J Med 2022;386:942-950.

  2. Abu-Raddad LJ, Chemaitelly H, Ayoub HH, AlMukdad S, et al.
    Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    N Engl J Med 2022.

  3. Gritsch S, Batchelor TT, Gonzalez Castro LN.
    Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
    Cancer 2022;128:47-58.

  4. Tesileanu CMS, Sanson M, Wick W, Brandes AA, et al.
    Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: post-hoc analysis of the EORTC randomized phase 3 CATNON trial.
    Clin Cancer Res 2022.

  1. Tomiczek-Szwiec J, Szwiec M, Falco M, Cybulski C, et al.
    The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
    Br J Cancer 2022.

  2. Chowdhury D, Mundra A, Datta D, Duggal A, et al.
    Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial.
    Cephalalgia 2022.

  3. Mark DB, Spertus JA, Bigelow R, Anderson S, et al.
    Comprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
    Circulation 2022.

  4. Estey E, Hasserjian RP, Dohner H.
    Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal.
    Blood 2022;139:323-332.

  5. Mamtani A, Sevilimedu V, Le T, Morrow M, et al.
    Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
    Cancer 2022;128:471-478.

  1. Tsivgoulis G, Triantafyllou S, Palaiodimou L, Grory BM, et al.
    Prolonged Cardiac Monitoring and Stroke Recurrence: A Meta-analysis.
    Neurology 2022.

  2. Markowitz LE, Schiller JT.
    Human Papillomavirus Vaccines.
    J Infect Dis 2021;224:S367-S378.

  3. Yaghi S, Shu L, Bakradze E, Salehi Omran S, et al.
    Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.
    Stroke 2022.

  4. Binder ZA, O'Rourke DM.
    Glioblastoma: The Current State of Biology and Therapeutic Strategies.
    Cancer Res 2022;82:769-772.

  5. Komen JJ, Pottegard A, Mantel-Teeuwisse AK, Forslund T, et al.
    Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
    Eur Heart J 2022.

  1. Murtomaki K, Mertsalmi T, Jaakkola E, Makinen E, et al.
    Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease.
    Mov Disord 2022.

  2. Sterenborg RBTM, Galesloot TE, Teumer A, Netea-Maier RT, et al.
    The effects of common genetic variation in 96 genes involved in thyroid hormone regulation on TSH and FT4 concentrations.
    J Clin Endocrinol Metab 2022.

  3. Fishel Bartal M, Sibai BM.
    Eclampsia in the 21st century.
    Am J Obstet Gynecol 2022;226:S1237-S1253.

  4. Rolnik DL, Nicolaides KH, Poon LC.
    Prevention of preeclampsia with aspirin.
    Am J Obstet Gynecol 2022;226:S1108-S1119.

  5. Saul H, Gursul D, Cassidy S, Vinogradova Y, et al.
    Risk of breast cancer with HRT depends on therapy type and duration.
    BMJ 2022;376:o485.


more..


Privacy Policy